Starling Oncology, Inc. Common Stock

STLNNASDAQ • USD
3.60 USD
↗ 0.06 (1.70%)🟢LIVE (AS OF 09:38 AM EST)
🟢Market: OPEN

STLN is currently priced at $3.60. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. This is driven by exceptional Return on Equity (92.2%) and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest STLN is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Nov 16, 2026.

Open?$3.52
High?$3.71
Low?$3.52
Prev. Close?$3.54
Volume?186.4K
Avg. Volume?3.6M
VWAP?$3.59
Rel. Volume?0.05x
Bid / Ask
Bid?$3.05 × 100
Ask?$4.10 × 100
Spread?$1.05
Midpoint?$3.57
Valuation & Ratios
Market Cap?361.0M
Shares Out?102.0M
Float?72.3M
Float %?72.3%
P/E Ratio?N/A
P/B Ratio?-9.67
EPS?-$0.34
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Starling Oncology Inc provides oncology care services in community settings. Its services include cancer diagnosis and treatment, clinical trials, transfusion services, and other oncology care delivery models for patients.
Employees
641
Market Cap
357.0M
Industry
SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
Listed
2021-11-15
Address
18000 STUDEBAKER RD
CERRITOS, CA 90703
Phone: 562-735-3226
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?9.46%Elevated
Short Interest?6.8M
Days to Cover?5.4
Free Float72.3M
Avg Daily Volume1.3M
Settlement Date2026-10-30
Financial Health
Current Ratio?1.11Adequate
Quick Ratio?0.82Weak
Cash Ratio?0.30Low
Debt/Equity?-2.08Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
S&P
97
-9.67CHEAP▾
P/S?
Peers
100
S&P
94
0.58CHEAP▾
P/FCF?
Peers
100
S&P
58
19.2CHEAP▾
EV/EBITDA?
S&P
97
-27.9CHEAP▾
EV/Sales?
Peers
100
S&P
97
0.65CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
92.2%STRONG▾
ROA?
S&P
3
-18.4%WEAK▾
Cash Flow & Enterprise
FCF?$18.8M
Enterprise Value?$401.7M
Fundamentals ratios updated end of day